Full Press Release Details
Shareholder Update: Creative Medical Technology Holdings, Inc.
Continues To Extinguish Debt
PHOENIX, April 30, 2018 /PRNewswire/ - Creative
Medical Technology Holdings, Inc. (OTCQB-CELZ) announced today that debt to two lenders in the amount of $163,000.00 has
As previously announced Creative Medical Technology Holdings,
Inc. has taken on debt in order to advance our technologies and continue towards our goal of commercialization and cash flow.
"We continue to focus on advancing commercialization of
our CaverStem procedure for the treatment of Erectile Dysfunction and the development of our issued patents for degenerative
disc disease (StemSpine ) and our amniotic derived stem cell (AmnioStem ), as well as patents pending in the area of
neurological damage due to radiation toxicity and stroke, amongst others. It is also our goal to continue to develop novel approaches
to regenerative medicine which will broaden our intellectual property pipeline," said Timothy Warbington, CEO of Creative
Medical Technology Holdings, Inc.
About Creative Medical Technology Holdings
Creative Medical Technology Holdings, Inc. is a commercial stage
biotechnology company currently trading on the OTCQB under the ticker symbol CELZ. For further information about the company go
to www.creativemedicaltechnology.com. For more information on our CaverStem
procedure please go to www.caverstem.com.
Forward-Looking Statements
OTC Markets has not reviewed and does not accept responsibility
for the adequacy or accuracy of this release. This news release may contain forward-looking statements including but not limited
to comments regarding the timing and content of upcoming clinical trials and laboratory results, marketing efforts, funding, etc.
Forward-looking statements address future events and conditions and, therefore, involve inherent risks and uncertainties. Actual
results may differ materially from those currently anticipated in such statements. See the periodic and other reports filed by
Creative Medical Technology Holdings, Inc. with the Securities and Exchange Commission and available on the Commission's website